| 靶点: |
IC50: 0.22 μM (PTP1B), 9.3 μM (TCPTP) |
| 体内研究: |
JTT 551 (3 mg/kg, 30 mg/kg, p.o.) dose-dependently decreases blood glucose level on Days 7, 14 and 28 in db/db Mice. JTT 551 also significantly reduces triglyceride (TG) level at 30 mg/kg on Day 7 but does not alter insulin and total cholesterol (TC) levels. |
| 参考文献: |
1. Fukuda S, et al. Pharmacological profiles of a novel protein tyrosine phosphatase 1B inhibitor, JTT-551. Diabetes Obes Metab. 2010 Apr;12(4):299-306. |
| 保存条件: |
-80℃,避光,干燥(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.651 ml |
8.253 ml |
16.506 ml |
| 5 mM |
0.33 ml |
1.651 ml |
3.301 ml |
| 10 mM |
0.165 ml |
0.825 ml |
1.651 ml |
| 50 mM |
0.033 ml |
0.165 ml |
0.33 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |